Removal of single-site N-linked glycans on factor VIII alters binding of domain-specific monoclonal antibodies.

Modifications of FVIII N-linked glycans reduced FVIII endocytosis by BMDCs and binding of domain-specific FVIII MAbs, but did not alter de novo antibody production in hemophilia A mice suggesting that N-glycans do not significantly contribute to inhibitor formation.